LONDON, Ontario – March 5, 2021: Indiva Limited (the “Company” or

“Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, is taking a bite out of the cannabis edible market with the launch of Wana Quick gummies (“Wana Quick”).

Produced in Canada by the same team that launched Wana Sour Gummies, the best-selling edible in the country, Indiva is now poised to launch three new Wana Quick flavours nationally in March 2021. The product will be available in Orchard Peach sativa, Pineapple Coconut indica and Strawberry Lime 1:1 hybrid. All Wana Quick gummies contain 10 mg of THC per package and are enhanced with over 30 terpenes to create an entourage effect for a greater experience.

Wana Quick gummies are made with pectin, not gelatin, which not only gives the gummies a great texture, but also makes them vegan and gluten-free. All gummies are handcrafted using a recipe intended to reduce melting.

“We couldn’t be more excited to present our new, terpene-enhanced cannabis gummies with all the great taste that Canadians have come to expect from Wana. Indiva has become synonymous with innovation, and Wana Quick gummies are a revolutionary product that really delivers,” said Leah Thiel, Marketing Director, Indiva.

Wana Quick uses a technology called Azuca TiME Infusion™, a patent-pending culinary innovation.

“We’re proud of the positive response we’ve received to Wana Sour Gummies across Canada and look forward to continuing to bring new and innovative products into the space,” added Thiel. “By putting Canadians’ desires first, we’re finding new ways to surprise and delight consumers with extraordinary cannabis experiences.”

The launch of Wana Quick comes on the heels of Wana Sour Gummies’

recognition from budtenders, receiving kind Magazine’s kind Award for 2020 Best Edible of the Year.

ABOUT INDIVA

Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, and edible products and provides production and manufacturing services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Wana™ Sour Gummies, Ruby® Jewels Chewable Tablets, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Artisan Batch, and other Powered by INDIVA™ products through license agreements and partnerships. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.

CONTACTS

INVESTOR CONTACT

Anthony Simone

Phone: 416-881-5154

Email: ir@indiva.com

ABOUT WANA BRANDS

Included in the 2020 Inc. 5000 list at #2,074 and boasting a three-year growth rate of 203%, Wana Brands is the No. 1 edibles brand in North America.

Wana™ leads the Canadian industry in providing a range of different options that enable customers to create the specific cannabis experience they want.

Wana products offer diverse product forms, four different CBD/THC ratios as well as a variety of different dosages. The portfolio is designed so products can be used singly or in combination to address specific recreational preferences. Wana Brands is available internationally in Canada through Indiva Inc. Follow Wana™ Canada on Instagram.

DISCLAIMER AND READER ADVISORY

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance.

The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company's future operations, future results, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry, future sales, the demand for the Company’s products and cannabis products generally and the continued operations of the Company in the ordinary course. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.